Waypoint Wealth Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Waypoint Wealth Counsel's LLY Position: Q1 2026 in Review
Waypoint Wealth Counsel reduced its Eli Lilly (LLY) stake by 40% in Q1 2026, selling an estimated $318K and leaving 464 shares worth $427K. The position accounts for 0.22% of the portfolio, ranked #97.
Waypoint Wealth Counsel first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $836K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Waypoint Wealth Counsel held 464 shares of Eli Lilly worth $427K as of Q1 2026.
- Waypoint Wealth Counsel sold 314 Eli Lilly shares in Q1 2026, an estimated $318K.
- Eli Lilly made up 0.22% of Waypoint Wealth Counsel's portfolio in Q1 2026, its #97 holding.
- Waypoint Wealth Counsel first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
- Waypoint Wealth Counsel's Eli Lilly position peaked at $836K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Waypoint Wealth Counsel's 13F filing for Q1 2026, filed 23 Apr 2026.